PortfoliosLab logoPortfoliosLab logo
ISIN
US9495031067
IPO Date
Feb 21, 2025

Highlights

Market Cap
$459.29M
Enterprise Value
$503.71M
EPS (TTM)
-$0.98
Total Revenue (TTM)
$14.03M
Gross Profit (TTM)
-$10.16M
EBITDA (TTM)
-$53.11M
Year Range
$3.04 - $97.50
ROA (TTM)
-254.21%
ROE (TTM)
508.46%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Wellgistics Health, Inc

Often compared with WGRX:
WGRX vs. NEUP

Performance

WGRX Performance Chart

Wellgistics Health, Inc (WGRX) is down 78.0% since the beginning of the year. At $4 per share, WGRX is trading 95.5% below its 52-week high of $98.


Loading charts...

S&P 500 Index

Returns By Period

Wellgistics Health, Inc (WGRX) has returned -78.02% so far this year and -95.30% over the past 12 months.


Wellgistics Health, Inc

1D
3.29%
1M
-15.58%
YTD
-78.02%
6M
-84.53%
1Y
-95.30%
3Y*
5Y*
10Y*

Benchmark (S&P 500 Index)

1D
-0.74%
1M
4.90%
YTD
10.35%
6M
10.28%
1Y
26.52%
3Y*
20.83%
5Y*
12.30%
10Y*
13.66%
*Multi-year figures are annualized to reflect compound growth (CAGR)

WGRX Monthly Returns History

Based on dividend-adjusted daily data since Feb 21, 2025, WGRX's average daily return is -0.30%, while the average monthly return is -14.01%.

Historically, 29% of months were positive and 71% were negative. The best month was Mar 2025 with a return of +60.0%, while the worst month was Mar 2026 at -59.7%. The longest winning streak lasted 2 consecutive months, and the longest losing streak was 7 months.

On a daily basis, WGRX closed higher 36% of trading days. The best single day was Oct 24, 2025 with a return of +185.4%, while the worst single day was May 8, 2025 at -30.6%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-10.24%-33.35%-59.67%14.11%-37.82%28.36%-78.02%
2025-29.13%60.00%0.46%-53.69%-51.81%-10.40%41.72%-27.88%-21.18%-14.17%-33.43%-89.51%

Benchmark Metrics

Wellgistics Health, Inc has an annualized alpha of -64.40%, beta of 1.37, and R2 of 0.01 versus S&P 500 Index. Calculated based on daily prices since February 24, 2025.

  • This stock participated in 417.09% of S&P 500 Index downside but only -169.33% of its upside - more exposed to losses than it benefited from rallies.
  • R2 of 0.01 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
-64.40%
Beta
1.37
0.01
Upside Capture
-169.33%
Downside Capture
417.09%

Return for Risk

Risk / Return Rank

WGRX ranks 15 for risk / return — in the bottom 15% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.


WGRX Risk / Return Rank: 1515
Overall Rank
WGRX Sharpe Ratio Rank: 2626
Sharpe Ratio Rank
WGRX Sortino Ratio Rank: 1717
Sortino Ratio Rank
WGRX Omega Ratio Rank: 1919
Omega Ratio Rank
WGRX Calmar Ratio Rank: 22
Calmar Ratio Rank
WGRX Martin Ratio Rank: 1111
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Wellgistics Health, Inc (WGRX) and compare them to S&P 500 Index.


WGRXBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

-2.60

Sortino ratioReturn per unit of downside risk

-3.76

Omega ratioGain probability vs. loss probability

0.93

1.41

-0.47

Calmar ratioReturn relative to maximum drawdown

-0.99

2.93

-3.91

Martin ratioReturn relative to average drawdown

-1.31

13.52

-14.83

Dividends

Dividend History


Wellgistics Health, Inc doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Wellgistics Health, Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Wellgistics Health, Inc was 98.73%, occurring on May 27, 2026. The portfolio has not yet recovered.

The current Wellgistics Health, Inc drawdown is 98.23%.


Related event

Drawdown

Fall

Recovery

Underwater

2026 bear market2026
-98.73%May 2026
1y 2mo
1y 2moMar 2025 - now
2025 selloff2025
-33.33%Mar 2025
15d7d
22dFeb 2025 - Mar 2025
2025 selloff2025
-0.50%Mar 2025
0s1d
1dMar 2025 - Mar 2025

Drawdown Indicators


WGRXBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-98.73%

-56.78%

-41.95%

Max Drawdown (1Y)

Largest decline over 1 year

-96.78%

-9.10%

-87.68%

Max Drawdown (3Y)

Largest decline over 3 years

-18.90%

Max Drawdown (5Y)

Largest decline over 5 years

-25.43%

Max Drawdown (10Y)

Largest decline over 10 years

-33.92%

Current Drawdown

Current decline from peak

-98.23%

-0.74%

-97.49%

Average Drawdown

Average peak-to-trough decline

-74.83%

-10.72%

-64.11%

Ulcer Index

Depth and duration of drawdowns from previous peaks

72.78%

1.97%

+70.81%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Wellgistics Health, Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Wellgistics Health, Inc is priced in the market compared to other companies in the Pharmaceutical Retailers industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for WGRX relative to other companies in the Pharmaceutical Retailers industry. Currently, WGRX has a P/S ratio of 24.4. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with WGRX

Add Wellgistics Health, Inc to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with WGRX